Developing better ways to measure eye inflammation in uveitis
UCLA/American Uveitis Society 2nd International Workshop on Objective Measures for Use in Clinical Trials
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-11000707
This study is all about finding better ways to measure eye inflammation caused by uveitis, and it's designed for early career researchers and trainees who want to work with experts to improve how we track and treat this condition.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-11000707 on ClinicalTrials.gov |
What this research studies
This research focuses on creating objective measures to detect and monitor intraocular inflammation associated with uveitis. It involves a workshop where early career researchers and trainees will collaborate with experts in the field to discuss and refine these measurement techniques. Participants will review existing methods, explore new techniques for quantifying inflammation, and work towards standardizing these measures for clinical trials. The workshop aims to foster collaboration among ophthalmologists, clinical trialists, and industry representatives to advance the understanding and treatment of inflammatory eye diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with uveitis or those at risk of developing inflammatory eye diseases.
Not a fit: Patients with non-inflammatory eye conditions or those not diagnosed with uveitis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved detection and monitoring of uveitis, potentially reducing the risk of blindness for patients.
How similar studies have performed: Previous workshops and research in this area have shown promise in developing standardized measures for clinical trials, indicating a potential for success in this ongoing effort.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TSUI, EDMUND — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: TSUI, EDMUND
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.